(RTTNews) - Supernus Pharmaceuticals Inc. (SUPN), Tuesday announced a licensing deal with M8 Pharmaceuticals to commercialize its ADHD drug Qelbree under the latter's trademark in Latin America.

Supernus Pharmaceuticals is furthering its collaboration with TV personality Jay Glazer by launching a new content series featuring his wife, Rosie Glazer, on the All About ADHD YouTube channel. This ...

Yahoo Sports Daily hosts Caroline Fenton and Jason Fitz are joined by NFL insider with Fox Sports Jay Glazer on behalf of ...

ADHD affects an estimated 10 million adults in the U.S. ROCKVILLE, Md., April 29, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company focused on developing and ...

Creekwood Pharmaceuticals was hit with a patent infringement lawsuit on July 11 in New Jersey District Court over its planned generic version of the ADHD medication Qelbree. The action, brought by ...

Aurobindo Pharma and its US subsidiary were hit with a patent infringement lawsuit on June 26 in New Jersey District Court over their attempt to market a generic version of the ADHD medication Qelbree ...

Females with ADHD frequently present with inattentive symptoms, which can be more difficult to recognize than the hyperactive and impulsive symptoms more often seen in males Boys are two times more ...